<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01464346</url>
  </required_header>
  <id_info>
    <org_study_id>CEP247</org_study_id>
    <nct_id>NCT01464346</nct_id>
  </id_info>
  <brief_title>A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use</brief_title>
  <official_title>A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Diabetes</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Diabetes</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the performance of the Enlite Sensor over an
      entire calibration and wear period of 146 hours (6 days) when inserted in the abdomen and
      buttock and used with the Revel 2.0 Pumps in subjects age 18 - 75 years.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">90</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enlite Sensor</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Type 1 or type 2 diabetes mellitus adult subjects 18-75 years of age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is 18 - 75 years of age at time of screening

          2. A clinical diagnosis of type 1 or 2 diabetes as determined by the

             Investigator, for a minimum of 12 months duration:

               -  Criteria for type 1 diabetes:

                    -  Required: Age of onset &lt; 40 years of age

                    -  Required: History of insulin use only for management of diabetes

                    -  Required: history of normal weight or underweight at time of diagnosis.

                    -  Not required: Initial presentation of diabetic ketoacidosis.

                    -  Not required: History of diabetic ketoacidosis

                    -  Not required: Low fasting C-peptide

               -  Criteria for type 2 diabetes:

                    -  Required: Age of onset ~ 40 years of age

                    -  Required: History of initial oral anti-diabetic use

                    -  Required: History of being overweight at time of diagnosis.

                         -  Type 2 insulin requiring is defined by type 2 diabetes subjects taking
                            insulin with or without oral anti-diabetic agent and may also include:
                            incretin mimetic, pramlintide or GLP agonist

                         -  Type 2 non-insulin requiring is defined by type 2 diabetes subjects who
                            take oral medications and may also include: incretin mimetic,
                            pramlintide or GLP agonist

          3. Adequate venous access as assessed by investigator or appropriate staff

        Exclusion Criteria:

          1. Subject is unable to tolerate tape adhesive in the area of sensor placement.

          2. Subject has any unresolved adverse skin condition in the area of sensor or device
             placement (e.g., psoriasis, rash, Staphylococcus infection)

          3. Subject is actively participating in an investigational study (drug or device) wherein
             they have received treatment from an investigational study (drug or device) in the
             last 2 weeks

          4. Subject has a positive pregnancy screening test

          5. Subject is female and plans to become pregnant during the course of the study

          6. Subject has had a hypoglycemic seizure within the past 6 months

          7. Subject has a history of a seizure disorder

          8. Subject has central nervous system or cardiac disorder resulting in syncope

          9. Subject has a history of myocardial infarction, unstable angina, coronary artery
             bypass surgery, coronary artery stenting, transient ischemic attack (TIA),
             cerebrovascular accident (CVA), angina, congestive heart failure, ventricular rhythm
             disturbances or thromboembolic disease

         10. Subjects with hematocrit lower than 36%

         11. SUbjects with a history of any cardiac arrhythmia, including atrial arrhythmias

         12. Subjects with a history of adrenal insufficiency

         13. Subjects with migraines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Lee, MD</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic Diabetes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Profil Institute for Clinical Research</name>
      <address>
        <city>Chula Vista</city>
        <state>California</state>
        <zip>91911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AMCR Institue</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diablo Clinical Research</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Denver/Barbara Davis Center for Childhood Diabetes</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainier Clinical Research Center</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2011</study_first_submitted>
  <study_first_submitted_qc>November 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2011</study_first_posted>
  <last_update_submitted>May 24, 2012</last_update_submitted>
  <last_update_submitted_qc>May 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>glucose sensor</keyword>
  <keyword>CGM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 23, 2013</submitted>
    <returned>December 13, 2013</returned>
    <submitted>December 13, 2013</submitted>
    <returned>January 31, 2014</returned>
    <submitted>March 31, 2014</submitted>
    <returned>April 30, 2014</returned>
    <submitted>May 25, 2017</submitted>
    <returned>June 26, 2017</returned>
    <submitted>August 11, 2017</submitted>
    <returned>September 14, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

